Saturday, July 11, 2026

Drug profile · INN

blarcamesine

blarcamesine (BLARCAMESINE ANAVEX) is an FDA-listed pharmaceutical active ingredient.

EMA: application withdrawn Nervous system (N06) N06D
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — blarcamesine
Class
Nervous system (N06)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

blarcamesine (BLARCAMESINE ANAVEX) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN blarcamesine
Brand BLARCAMESINE ANAVEX
Therapeutic class Nervous system (N06)
ATC code N06D

Approval history

Authority Status Date
EMA application withdrawn

Related & competitor drugs

  1. aripiprazole Nervous system (N05)
  2. brexpiprazole Nervous system (N05)
  3. brivaracetam Nervous system (N03)
  4. bupivacaine Nervous system (N01)
  5. buprenorphine Nervous system (N07)
  6. caffeine citrate Nervous system (N06)

Frequently asked questions

What is blarcamesine?

blarcamesine (BLARCAMESINE ANAVEX) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for blarcamesine?

BLARCAMESINE ANAVEX is a marketed brand name for blarcamesine. Check FDA Drugs@FDA for the current US label holder and prescribing information.